共 50 条
- [41] Recent advances in the treatment of hormone receptor positive HER2 negative metastatic breast cancerCRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2015, 94 (03) : 291 - 301Fedele, PalmaOrlando, LauraSchiavone, PaolaCalvani, NicolaCaliolo, ChiaraQuaranta, AnnamariaNacci, AngeloCinieri, Saverio
- [42] Association of HER2 alterations and ESR1 mutations in cell-free DNA (cfDNA) with circulating tumor cells (CTCs), multiple metastasis, and prognosis in stage III/IV breast cancer (BCa).JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)Zhang, QiangGerratana, LorenzoShah, Ami N.Davis, Andrew A.Flaum, Lisa E.Zhang, YoubinQiang, WenanBehdad, AmirGradishar, William JohnPlatanias, Leonidas C.Cristofanilli, Massimo
- [43] Determination of HER2 Status with Analysis of Plasma DNA by Digital PCR in Patients with Metastatic Breast Cancer.CANCER RESEARCH, 2011, 71Graeser, M. K.Gevensleben, H.Smith, I. E.Ashworth, A.Turner, N. C.
- [44] Analysis of genomic alterations in cell free DNA and gut bacterial diversity in metastatic breast cancer (MBC) patients on endocrine therapy: A pilot studyCANCER RESEARCH, 2021, 81 (04)Pezo, Rossanna C.Eisen, AndreaGandhi, SonalWarner, EllenJerzak, KatarzynaTrudeau, MaureenSeth, Arun
- [45] Serum HER2 extracellular domain levels and HER2 circulating tumor cell status in patients with metastatic breast cancerFUTURE ONCOLOGY, 2016, 12 (17) : 2001 - 2008Aurilio, GaetanoSandri, Maria TeresaPruneri, GiancarloZorzino, LauraBotteri, EdoardoMunzone, ElisabettaAdamoli, LauraFacchi, GiuseppinaCullura, DanielaVerri, ElenaRocca, Maria CossuZurrida, StefanoIacovelli, RobertoNole, Franco
- [46] Genomic alterations of cell-free DNA in early breast cancer patients with recurrenceCANCER RESEARCH, 2019, 79 (04)Kim, J.Jo, W. K.Kim, K. Y.Kim, B. J.Lee, S. B.Lee, H. J.Yu, J. H.Kim, H. J.Chung, I. Y.Ko, B. S.Kim, S-BJung, K. H.Ahn, J. H.Chang, S.Lee, J. W.Son, B. H.Ahn, S. H.
- [47] The combined blood analysis of cell-free DNA and genomic DNA of circulating tumor cells reveals additive value in hormone receptor-positive, HER2-negative metastatic breast cancer patientsCANCER RESEARCH, 2020, 80 (04)Keup, CorinnaBittner, Ann-KathrinHoffmann, OliverTewes, MitraStorbeck, MarkusHahn, PeterHauch, SiegfriedSprenger-Haussels, MarkusKimmig, RainerKasimir-Bauer, Sabine
- [48] Prognostic role of PIK3CA mutational status in cell free DNA (cfDNA) from HER2-positive metastatic breast cancer patientsBREAST, 2017, 32 : S66 - S67Lee, K-HLim, J.Min, A.Kim, S-GKim, J-EKim, T-YHan, S-WOh, D-YKim, T-YIm, S-A
- [49] Breast Cancer Biomarker Changes and Correlations with HER2 Change in ER Positive, HER2 Negative Breast Cancers Treated with Neoadjuvant Endocrine TherapyLABORATORY INVESTIGATION, 2024, 104 (03) : S175 - S176Huang, WeiTyburski, HaleyFinkelman, BrianTurner, BradleyWeiss, AnnaDhakal, AjaySkinner, KristinHicks, DavidZhang, Huina
- [50] Identification of pathogenic ROSI alterations in cell-free DNA (cfDNA) from patients with breast cancer.JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)Force, Jeremy MeyerTaylor, Mary LoveDrusbosky, LeylahYen, JenniferMarcom, Paul KellyAnders, Carey K.Marks, Jeffrey R.